The Phase III trial AV001 aims to evaluate QUTENZA ® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical ...
A small 2020 study involving 29 people with peripheral neuropathy looked at the effectiveness of topical CBD oil for pain. The participants were divided into two groups: a treatment group that ...
Aachen, Germany, & Morristown, N.J., 7 November 2024 (News Aktuell) – Grünenthal announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical ...
Jiangsu Alicorn Pharmaceutical Co. Ltd. has described AP2-associated protein kinase 1 (AAK1) inhibitors reported to be useful for the treatment of Alzheimer’s disease, bipolar disorder, Parkinson’s ...